Literature DB >> 10560690

Long QT syndromes and torsade de pointes.

S Viskin1.   

Abstract

In the long QT syndromes (LQTS), malfunction of ion channels impairs ventricular repolarisation and triggers a characteristic ventricular tachyarrhythmia: torsade de pointes. Symptoms in the LQTS (syncope or cardiac arrest) are caused by this arrhythmia. In congenital LQTS, mutations in the genes encoding for ion channels cause this channel malfunction. Six genotypes (LQT1 to LQT6) have been identified, and attempts are being made to correlate different mutations with clinical signs and specific therapy. In acquired LQTS, channel malfunction is caused by metabolic abnormalities or drugs. The list of drugs that may impair ion-channel function expands continuously. Moreover, attributes that increase the risk for drug-induced torsade (eg, female sex, recent heart-rate slowing, or hypokalaemia) and electrocardiographic "warning signs" are recognised. Recent data suggest that patients with an acquired LQTS have some underlying predisposition to proarrhythmia. Mutations causing "silent" forms of congenital LQTS, in which the patient remains free of arrhythmias until exposed to drugs that further impair repolarisation, are now recognised.

Entities:  

Mesh:

Year:  1999        PMID: 10560690     DOI: 10.1016/S0140-6736(99)02107-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  132 in total

1.  Channel structure and drug-induced cardiac arrhythmias.

Authors:  R S Kass; C Cabo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-24       Impact factor: 11.205

Review 2.  The molecular basis of cardiac arrhythmias.

Authors:  Kalyanam Shivkumar; Narayana S Murali; Subramaniam C Krishnan
Journal:  J Nucl Cardiol       Date:  2002 Mar-Apr       Impact factor: 5.952

3.  If it's not epilepsy...

Authors:  P E Smith
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-06       Impact factor: 10.154

Review 4.  Drug-induced proarrhythmic effects: assessment of changes in QT interval.

Authors:  D J Sheridan
Journal:  Br J Clin Pharmacol       Date:  2000-10       Impact factor: 4.335

5.  Effects of dose ranging of adenosine infusion on electrocardiographic findings during and after general anesthesia.

Authors:  Yan-Xia Sun; Ashraf S Habib; Tom Wenger; Irwin Gratz; David Glick; Rishimani Adsumelli; Mary R Creed; Tong J Gan
Journal:  J Anesth       Date:  2012-06-03       Impact factor: 2.078

6.  When u say "U Waves," what do u mean?

Authors:  Sami Viskin; David Zelster; Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2004-02       Impact factor: 1.976

7.  Inhibitory actions of HERG currents by the immunosuppressant drug cyclosporin a.

Authors:  Seung Ho Lee; Sang June Hahn; Gyesik Min; Jimok Kim; Su-Hyun Jo; Han Choe; Bok Hee Choi
Journal:  Korean J Physiol Pharmacol       Date:  2011-10-31       Impact factor: 2.016

8.  The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes.

Authors:  Elijah R Behr; Craig January; Eric Schulze-Bahr; Andrew A Grace; Stefan Kääb; Monica Fiszman; Shaniece Gathers; Shaavhrée Buckman; Ashraf Youssef; Munir Pirmohamed; Dan Roden
Journal:  Eur Heart J       Date:  2012-07-02       Impact factor: 29.983

9.  Effects of head-up tilt-table test on the QT interval.

Authors:  Michael Findler; Amir Birger; Shmuel Diamant; Sami Viskin
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

10.  Electrocardiographic predictors of adverse cardiovascular events in suspected poisoning.

Authors:  Alex F Manini; Lewis S Nelson; Adam H Skolnick; William Slater; Robert S Hoffman
Journal:  J Med Toxicol       Date:  2010-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.